NKGen Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NKGen Biotech and buy or sell other stocks, ETFs, and their options commission-free!

About NKGN

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. 

CEO
Paul Y. Song
CEOPaul Y. Song
Employees
26
Employees26
Headquarters
Santa Ana, California
HeadquartersSanta Ana, California
Founded
2017
Founded2017
Employees
26
Employees26

NKGN Key Statistics

Market cap
1.31M
Market cap1.31M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
2.34K
Average volume2.34K
High today
$0.01
High today$0.01
Low today
$0.01
Low today$0.01
Open price
$0.01
Open price$0.01
Volume
500.00
Volume500.00
52 Week high
$0.20
52 Week high$0.20
52 Week low
$0.001
52 Week low$0.001

Stock Snapshot

The current NKGen Biotech(NKGN) stock price is $0.01, with a market capitalization of 1.31M.

On 2026-10-24, NKGen Biotech(NKGN) stock moved within a range of $0.01 to $0.01. With shares now at $0.01, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading volume for NKGen Biotech(NKGN) stock has reached 500, versus its average volume of 2.34K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.20.

The stock's 52-week range extends from a low of $0.00 to a high of $0.20.

People also own

Based on the portfolios of people who own NKGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.